Comparison of cytokine adsorption ability between AN69ST and PMMA hemofilter in patients with sepsis

Comparison of cytokine adsorption ability between AN69ST and PMMA hemofilter in patients with sepsis - Comparison of cytokine adsorption ability between AN69ST and PMMA hemofilter in patients with sepsis

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029450

Enrollment

Registered

2017-11-01

Start date

2017-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Blood purification usign AN69ST hemofilter Blood purification usign PMMA hemofilter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: >=18 years of age sepsis (including COVID-19) acute kidney injury (according to RIFLE or KDIGO criteria) able to provide informed concent

Exclusion criteria

Exclusion criteria: patients considered ineligible for the study by the investigator

Design outcomes

Primary

Measure	Time frame
1.cytokine clearance 2.HMGB1 absorption at 2-6 hours and 12-24 hours after blood purification	—

Countries

Japan

Contacts

Public ContactYoshihiko Nakamura

Faculty of Medicine, Fukuoka University Department of Emergency and Critical Care Medicine

pdmxy827@yahoo.co.jp092-801-1011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026